Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

33%

Ph phase_4

33%

Ph phase_2

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

Phase 2Efficacy & side effects

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(1)

Detailed Status

Completed2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (33.3%)

Phase 21 (33.3%)

Phase 41 (33.3%)

Trials by Status

completed267%

unknown133%

Recent Activity

0 active trials

Showing 3 of 3

completedphase_2

Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction

NCT05388825

completedphase_4

Impact of Dapagliflozin on DIAstolic Dysfunction in Type 2 Diabetic Patients

NCT02751398

unknownphase_1

Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects

NCT04178070

Clinical Trials (3)

Showing 3 of 3 trials

NCT05388825Phase 2

Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction

Completed

NCT02751398Phase 4

Impact of Dapagliflozin on DIAstolic Dysfunction in Type 2 Diabetic Patients

Completed

NCT04178070Phase 1

Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects

Unknown

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3